Frequency of MET amplification determined by comprehensive next-generation sequencing (NGS) in multiple solid tumors and implications for use of MET inhibitors.
Norma Alonzo Palma
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Gary A. Palmer
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Siraj M. Ali
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Philip J. Stephens
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Jeffrey S. Ross
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Doron Lipson
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine